Aclaris Therapeutics Inc (0H8T)
LSE
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 1.68M | 10.09M | 4.23M | 6.48M | 6.76M | 29.75M | 31.25M |
| Operating Income | -48.57M | -72.42M | -135.41M | -111.06M | -50.91M | -65.38M | -85.15M | -124.26M |
| Pre Tax Income | -48.08M | -70.35M | -132.74M | -113.54M | -51.34M | -90.87M | -86.91M | -88.85M |
| Net Income | -48.08M | -68.52M | -132.74M | -161.35M | -51.02M | -90.87M | -86.91M | -88.48M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -1.845 | -2.221 | -3.221 | -3.889 | -1.131 | -1.484 | -1.303 | -1.249 |
| EBIT | -48.08M | -70.35M | -132.74M | -113.54M | -51.34M | -66.53M | -82.21M | -115.75M |
| EBITDA | -48.45M | -72.02M | -133.54M | -90.97M | -49.59M | -64.46M | -84.36M | -116.77M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
